1 / 23

Robert J Nicolosi - Director

MicroFluidics Technology Fair. Nanoemulsion Delivery of Pharmaceutical, Nutraceuticals and Cosmeceuticals In vitro and In vivo studies October 3, 2006. Center for Health and Disease Research. Robert J Nicolosi - Director. Illustration of a Nano-Emulsion.

Download Presentation

Robert J Nicolosi - Director

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MicroFluidics Technology Fair Nanoemulsion Delivery of Pharmaceutical, Nutraceuticals and Cosmeceuticals In vitro and In vivo studies October 3, 2006 Center for Health and Disease Research Robert J Nicolosi - Director

  2. Illustration of a Nano-Emulsion Nanoparticles (via AFM)) • The inner core consisting of any oil • Drug or nutrient molecules within the core • The emulsifier layer surrounding the nano-particle.

  3. Characteristics of Nanoemulsions • Stable at temperatures up to 110° C and from pH < 2.0 – 8.0 • 6 month stability (at least) • Range of particle sizes (25-100 nm) • Converts fat soluble chemicals to stable water dispersions

  4. Nanoemulsions of Tocopherol

  5. Does Size make a difference in Efficacy of Delivering Tocopherol as a Micro (10-6) vs Nanoemulsion (10-9)

  6. Vitamin E Enhancing Bioactivity: Microemulsion vs.NanoEmulsifion Reactive Oxygen Species (ROS) Nanoemulsions of Vitamin E are 100 times more active than Microemulsion Encapsulated Vitamin E in cell culture.

  7. Transdermal Delivery of Tocopherol: Effect on Blood Levels in Hamsters (n=7) 3.7 ug/mL Tocopherol Tocopherol alone Nanoemulsion Of Tocopherol 2.09 ug/ml Tocopherol μg/mL 1 2 3 (Submitted 2006) Hours

  8. Nanoemulsion delivery of anti- inflammatory agent Aspirin in mice

  9. (JACS 2005)

  10. “Anti-oxidant Synergy Formulation” suppresses malignancy: Nanoemulsions improve its effectiveness in culture Taxol • ASF forces differentiation of neuroblastoma (most common solid tumor in children)...Like neurons, if they begin to differentiate, they no longer multiply

  11. ASF Studies (In vivo) • Nude Mice • since they lack a fully-functional immune system • Injection of Cancer Cells • by subcutaneous injection of Mouse or Human Cancer cells (300,000 cells /ml) • Injection of ASF solution • once tumors were detected • Measure the tumor diameter • quantified daily in accordance with the longest diameter

  12. The neuroblastoma in the nude mice Tumor Control (no treatment) No Tumor ASF Nano-emulsion

  13. Subcut Injection vs Topical Delivery of ASF containing- nanoemulsions on neuroblastoma–induced tumor growth rate. - 4% - 65% - 63% Subcut inj Subcut inj Transdermal ( In press 2006)

  14. Nanoemulsion delivery of Tamoxifen to breast cancer cell lines

  15. The Effect of Tamoxifen (T) and a Nanoemulsion Preparation of Tamoxifen (NT) on Cell Proliferation C T NT 1 3 5 7 10 12 Days of Culture

  16. Dacarbazine Nano-emulsion Treatment in a Zenograft Melanoma Mouse Model

  17. Tumor Reduction with Nano preparations of Dacarbazine p < 0.0007 P < 0.000003 P <0.0001 10x -4% 2x - 30% - 49% - 62% Nano Control Dacarbazine Dacarbazine Topical IM Topical IM

  18. Tumor Growth in Mice after Dacarbazine Administration is Stopped for 12 Weeks + 43% + 30% Control Drug Topical - 18% - 23% - 92% Drug Nano-Drug IM Topical Nano-Drug IM

  19. Anti-Bacterial indication of Nanoemulsions

  20. Microemulsion versus Nanoemulsion of Soy Protein Nanoemulsified Homogenized Nanoemulsions are stable dispersions which do not agglomerate and which demonstrate antimicrobial activity

  21. Gram + Staph Aureus Bacteria Staph Aureus Control Staph aureus streaked empty nanoemulsion

  22. Summary • Nanoemulsion technology produces • particle sizes in the 25-100 nm range. • The technology converts fat soluble to • water soluble compounds. • The technology can deliver pharmaceuticals, • nutraceuticals and cosmeceuticals. • The particle size reduction is associated • with increased bioavailability and efficacy.

  23. Acknowledgements Doctoral Students in the Biomedical Engineering & Biotechnology Program Jean-Bosco Tagne Srikanth Kakumanu Fongshu Kuo Balaji Karthick Rohini Vishwanathan Mukta Bagul Microfluidics (MFIC) Corp, Newton MA 02469

More Related